Literature DB >> 12202596

Labor and cost requirements of two commercial assays for qualitative molecular detection of hepatitis C virus.

Iris Schrijver1, Ellen Jo Baron.   

Abstract

The Bayer transcription-mediated amplification (TMA) and the Roche PCR Amplicor version 2.0 molecular assays for the qualitative detection of hepatitis C virus were compared for cost, hands-on time, assay duration, and complexity. The TMA assay compares well to PCR and may be especially useful for laboratories with large numbers of test requests.

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12202596      PMCID： PMC130744          DOI： 10.1128/JCM.40.9.3476-3477.2002

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  6 in total

1.  Transcription-mediated amplification is more sensitive than conventional PCR-based assays for detecting residual serum HCV RNA at end of treatment.

Authors:  L Comanor; F Anderson; M Ghany; R Perrillo; E J Heathcote; C Sherlock; I Zitron; D Hendricks; S C Gordon
Journal:  Am J Gastroenterol       Date:  2001-10       Impact factor: 10.864

Review 2.  New perspectives in the diagnosis of hepatitis C.

Authors:  E R Schiff; M de Medina; R S Kahn
Journal:  Semin Liver Dis       Date:  1999       Impact factor: 6.115

3.  Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome.

Authors:  Q L Choo; G Kuo; A J Weiner; L R Overby; D W Bradley; M Houghton
Journal:  Science       Date:  1989-04-21       Impact factor: 47.728

4.  Prospective multicenter clinical evaluation of AMPLICOR and COBAS AMPLICOR hepatitis C virus tests.

Authors:  F S Nolte; M W Fried; M L Shiffman; A Ferreira-Gonzalez; C T Garrett; E R Schiff; S J Polyak; D R Gretch
Journal:  J Clin Microbiol       Date:  2001-11       Impact factor: 5.948

Review 5.  Hepatitis C: a hepatologist's approach to an infectious disease.

Authors:  P M Rosenberg
Journal:  Clin Infect Dis       Date:  2001-10-10       Impact factor: 9.079

6.  Comparison of three HCV genotyping assays: a serological method as a reliable and inexpensive alternative to PCR based assays.

Authors:  M Schröter; B Zöllner; P Schäfer; R Laufs; H H Feucht
Journal:  J Clin Virol       Date:  2001-12       Impact factor: 3.168
  6 in total
  1 in total

1.  Maximizing gain in high-throughput screening using conformal prediction.

Authors:  Fredrik Svensson; Avid M Afzal; Ulf Norinder; Andreas Bender
Journal:  J Cheminform       Date:  2018-02-21       Impact factor: 5.514
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.